Literature DB >> 24421789

Feasibility and success of HIV point-of-care testing in an emergency department in an urban Canadian setting.

Marissa L Becker1, Laura H Thompson2, Carla Pindera3, Natalie Bridger4, Carmen Lopez5, Yoav Keynan6, Jared Bullard7, Paul Van Caseele7, Ken Kasper8.   

Abstract

BACKGROUND: Approximately 26% of Canadians living with HIV are unaware of their status. Point-of-care (POC) HIV tests have been introduced to simplify and expand HIV testing.
OBJECTIVE: To evaluate the feasibility and acceptability of POC testing in an emergency department (ED) setting in Winnipeg, Manitoba.
METHODS: A cross-sectional study of unselected adults presenting to the ED at the Health Sciences Centre Hospital (Winnipeg, Manitoba) was performed. Study procedures included pre- and post-test counselling, administration of the INSTI HIV-1/HIV-2 Antibody Test (bioLytical Laboratories, Canada) and a brief questionnaire. Venous blood samples were collected from participants for confirmatory testing on all reactive and indeterminate specimens.
RESULTS: In total, 501 adults participated in the study. The majority of participants were younger than 40 years of age, approximately one-half (48.5%) were women and 53% self-identified as Aboriginal. Nearly one-half (49.1%) of the participants had undergone previous HIV testing, although 63% of these tests were performed more than a year earlier. A total of seven individuals tested reactive with the POC test, all of whom were confirmed positive using serological testing (1.4%) and were linked to an HIV specialist within 24 h. Nearly all of the participants (96%) reported satisfaction with the test and believed it belonged in the ED (93%).
CONCLUSIONS: Of the participants tested, 1.4% tested reactive for HIV, which is significantly higher than the reported prevalence in Manitoba and in other similar studies conducted in North America. Furthermore, all individuals were linked to timely care. The present study demonstrated that this particular busy tertiary care ED is an important and feasible location for HIV POC testing.

Entities:  

Keywords:  Emergency departments; HIV; Testing

Year:  2013        PMID: 24421789      PMCID: PMC3630025          DOI: 10.1155/2013/164797

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  23 in total

Review 1.  Late diagnosis of HIV infection: major consequences and missed opportunities.

Authors:  Martin Fisher
Journal:  Curr Opin Infect Dis       Date:  2008-02       Impact factor: 4.915

2.  Projected life expectancy of people with HIV according to timing of diagnosis.

Authors:  Fumiyo Nakagawa; Rebecca K Lodwick; Colette J Smith; Ruth Smith; Valentina Cambiano; Jens D Lundgren; Valerie Delpech; Andrew N Phillips
Journal:  AIDS       Date:  2012-01-28       Impact factor: 4.177

Review 3.  Rapid HIV screening in the emergency department.

Authors:  Mercedes Torres
Journal:  Emerg Med Clin North Am       Date:  2010-05       Impact factor: 2.264

4.  Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel.

Authors:  Melanie A Thompson; Judith A Aberg; Pedro Cahn; Julio S G Montaner; Giuliano Rizzardini; Amalio Telenti; José M Gatell; Huldrych F Günthard; Scott M Hammer; Martin S Hirsch; Donna M Jacobsen; Peter Reiss; Douglas D Richman; Paul A Volberding; Patrick Yeni; Robert T Schooley
Journal:  JAMA       Date:  2010-07-21       Impact factor: 56.272

5.  Advancing HIV prevention: new strategies for a changing epidemic--United States, 2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2003-04-18       Impact factor: 17.586

6.  Routine HIV screening in the emergency department using the new US Centers for Disease Control and Prevention Guidelines: results from a high-prevalence area.

Authors:  Jeremy Brown; Robert Shesser; Gary Simon; Maria Bahn; Maggie Czarnogorski; Irene Kuo; Manya Magnus; Neal Sikka
Journal:  J Acquir Immune Defic Syndr       Date:  2007-12-01       Impact factor: 3.731

7.  The high cost of medical care for patients who present late (CD4 <200 cells/microL) with HIV infection.

Authors:  H B Krentz; M C Auld; M J Gill
Journal:  HIV Med       Date:  2004-03       Impact factor: 3.180

8.  Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study.

Authors:  Margaret May; Mark Gompels; Valerie Delpech; Kholoud Porter; Frank Post; Margaret Johnson; David Dunn; Adrian Palfreeman; Richard Gilson; Brian Gazzard; Teresa Hill; John Walsh; Martin Fisher; Chloe Orkin; Jonathan Ainsworth; Loveleen Bansi; Andrew Phillips; Clifford Leen; Mark Nelson; Jane Anderson; Caroline Sabin
Journal:  BMJ       Date:  2011-10-11

9.  The Prevalence of Undiagnosed HIV Infection in Those Who Decline HIV Screening in an Urban Emergency Department.

Authors:  M Czarnogorski; J Brown; V Lee; J Oben; I Kuo; R Stern; G Simon
Journal:  AIDS Res Treat       Date:  2011-05-09

10.  The Direct Medical Costs of Late Presentation (<350/mm) of HIV Infection over a 15-Year Period.

Authors:  Hartmut B Krentz; M John Gill
Journal:  AIDS Res Treat       Date:  2011-08-29
View more
  12 in total

1.  Tuberculosis among northern Manitoba First Nations, 2008-2012: program performance on- and off-reserve.

Authors:  C Andrew Basham; Brenda Elias; Anne Fanning; Pamela Orr
Journal:  Can J Public Health       Date:  2019-07-08

2.  Prevalence of HIV infection and acceptability of point-of-care testing in a Canadian inner-city emergency department.

Authors:  Rob Stenstrom; Daphne Ling; Eric Grafstein; Rolando Barrios; Chris Sherlock; Reka Gustafson; Farzaneh Osati; Iraj Poureslami; Aslam Anis
Journal:  Can J Public Health       Date:  2016-10-20

Review 3.  The Continuum of HIV Care in Rural Communities in the United States and Canada: What Is Known and Future Research Directions.

Authors:  Katherine R Schafer; Helmut Albrecht; Rebecca Dillingham; Robert S Hogg; Denise Jaworsky; Ken Kasper; Mona Loutfy; Lauren J MacKenzie; Kathleen A McManus; Kris Ann K Oursler; Scott D Rhodes; Hasina Samji; Stuart Skinner; Christina J Sun; Sharon Weissman; Michael E Ohl
Journal:  J Acquir Immune Defic Syndr       Date:  2017-05-01       Impact factor: 3.731

4.  Pulmonary tuberculosis in outpatients in Sabah, Malaysia: advanced disease but low incidence of HIV co-infection.

Authors:  Timothy William; Uma Parameswaran; Wai Khew Lee; Tsin Wen Yeo; Nicholas M Anstey; Anna P Ralph
Journal:  BMC Infect Dis       Date:  2015-01-31       Impact factor: 3.090

5.  Evaluation of the Utility of Point-of-Care HIV Testing on a Canadian Internal Medicine Inpatient Unit.

Authors:  Lawrence Lau; Beverly Wudel; Eugene Lee; Majid Darraj; Quinlan Richert; Adriana Trajtman; Kim Bresler; Jared Bullard; Ken Kasper; Marissa Becker; Yoav Keynan
Journal:  Can J Infect Dis Med Microbiol       Date:  2017-11-02       Impact factor: 2.471

Review 6.  HIV Point-of-Care Testing in Canadian Settings: A Scoping Review.

Authors:  Alexa Minichiello; Michelle Swab; Meck Chongo; Zack Marshall; Jacqueline Gahagan; Allison Maybank; Aurélie Hot; Michael Schwandt; Sonia Gaudry; Oliver Hurley; Shabnam Asghari
Journal:  Front Public Health       Date:  2017-04-18

7.  Seroprevalence of HCV, HBV and HIV in two inner-city London emergency departments.

Authors:  L Cieply; R Simmons; S Ijaz; E Kara; A Rodger; W Rosenberg; A McGuinness; J L Mbisa; J Ledesma; N Ohemeng-Kumi; S Dicks; H Potts; S Lattimore; S Mandal
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

8.  A Dene First Nation's community readiness assessment to take action against HIV/AIDS: a pilot project.

Authors:  Linda Larcombe; Albert McLeod; Sarah Samuel; Jennifer Samuel; Michael Payne; Stephanie Van Haute; Matthew Singer; Laurie Ringaert; Adrienne F A Meyers; Kathi Kinew; Yoav Keynan; Kelly MacDonald; Joe Antsanen; Pamela Orr
Journal:  Int J Circumpolar Health       Date:  2019-12       Impact factor: 1.228

9.  Laboratory Evaluation of a Point-of-Care Downward-Flow Assay for Simultaneous Detection of Antibodies to Treponema pallidum and Human Immunodeficiency Virus.

Authors:  S Herbst de Cortina; C C Bristow; S K Vargas; D G Perez; K A Konda; C F Caceres; J D Klausner
Journal:  J Clin Microbiol       Date:  2016-05-04       Impact factor: 5.948

Review 10.  Measures and Metrics for Feasibility of Proof-of-Concept Studies With Human Immunodeficiency Virus Rapid Point-of-Care Technologies: The Evidence and the Framework.

Authors:  Nitika Pant Pai; Tiago Chiavegatti; Rohit Vijh; Nicolaos Karatzas; Jana Daher; Megan Smallwood; Tom Wong; Nora Engel
Journal:  Point Care       Date:  2017-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.